Literature DB >> 29543697

Nutritional Status in the First 2 Years of Life in Cystic Fibrosis Diagnosed by Newborn Screening.

Anne Munck1, Rym Boulkedid2, Laurence Weiss3, Pierre Foucaud4, Nathalie Wizla-Derambure5, Philippe Reix6, François Bremont7, Jocelyne Derelle8, Julien Schroedt2, Corinne Alberti2.   

Abstract

OBJECTIVE: To evaluate nutritional status and associated factors in a cystic fibrosis (CF) cohort diagnosed by newborn screening and followed up to month 24.
METHODS: A prospective longitudinal multicenter study assessing nutritional status according to pancreatic status, feeding modalities, prescriptions, pulmonary outcome, and biological nutritional parameters.
RESULTS: One hundred and five infants were recruited and 99 completed the study. Nutritional care management prevented undernutrition and stunting in those with exocrine pancreatic sufficiency (EPS), but affected (13/87) 15% and (21/86) 24%, respectively, of infants with exocrine pancreatic insufficiency (EPI). The logistic regression model found a positive association between both weight and length z scores "at risk" at month 24, and initial pulmonary symptoms (odds ratio [OR] 0.06, P < 0.01 and OR 0.08, P < 0.01, respectively); these symptoms were less frequent when age at first visit was earlier than 1.2 months (33% vs 67%, P = 0.02); stunting was also associated with high-calorie density intake and Staphylococcus aureus (OR 0.05, P = 0.01 and OR 0.17, P < 0.01). Pulmonary outcome did not differ according to pancreatic status; breast-feeding for at least 3 months delayed first acquisition of Pseudomonas aeruginosa. Despite sodium and fat-soluble vitamin supplementation, half of both cohorts had low urinary sodium output and half of the EPI cohort had low vitamin D levels.
CONCLUSIONS: Our data shed light on the fact that stunting was more frequent than undernutrition, while both parameters involved only patients with pancreatic insufficiency. Modalities of feeding were not associated with nutritional status; breast-feeding may provide some protection against acquisition of P aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29543697     DOI: 10.1097/MPG.0000000000001956

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  3 in total

1.  Zinc status and growth in infants and young children with cystic fibrosis.

Authors:  Sarah E Bauer; HuiChuan J Lai; Catherine M McDonald; Fadi Asfour; James E Slaven; Clement L Ren
Journal:  Pediatr Pulmonol       Date:  2021-09-17

2.  Academy of Nutrition and Dietetics: 2020 Cystic Fibrosis Evidence Analysis Center Evidence-Based Nutrition Practice Guideline.

Authors:  Catherine M McDonald; Jessica A Alvarez; Julianna Bailey; Ellen K Bowser; Kristen Farnham; Mark Mangus; Laura Padula; Kathleen Porco; Mary Rozga
Journal:  J Acad Nutr Diet       Date:  2020-06-19       Impact factor: 5.234

3.  Effect of malnutrition in infants with cystic fibrosis in India: An underestimated danger.

Authors:  Leenath Thomas; Shincy T John; B Arul P Lionel; Grace Rebekah; Madhan Kumar; Anu Punnen; Sneha Varkki
Journal:  J Family Med Prim Care       Date:  2021-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.